Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NASH
NASH
Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25%
Xconomy
Tue, 09/1/20 - 10:45 pm
Intercept Pharma
layoffs
NASH
FDA
Ocaliva
Novartis hands off NASH drug to biotech collaborator, also plans to build new Basel production unit
Endpoints
Tue, 09/1/20 - 11:05 am
Novarts
NASH
Boston Pharmaceuticals
BOS-580
Takeda inks up to $500M collaboration with extra-cellular matrix biotech for NASH
Endpoints
Tue, 08/25/20 - 09:52 pm
Takeda
NASH
Engitix
drug development
Merck scoops up a PhII J&J discard in a bargain-basement deal. And this time they’re shooting at NASH
Endpoints
Tue, 08/4/20 - 12:42 pm
Merck
JNJ
South Korea
Hanmi Pharma
HM12525A
NASH
Genfit abandons late-stage trial of NASH drug elafibranor
Pharmaforum
Thu, 07/23/20 - 10:39 am
Genfit
elafibranor
NASH
clinical trials
Gilead-partnered Glympse snares $46.7M for their NASH-snooping biosensors
Endpoints
Wed, 07/15/20 - 10:18 am
Glympse Bio
NASH
Gilead Sciences
Analysts hail Akero's midphase NASH data as best in class
Fierce Biotech
Thu, 07/2/20 - 11:10 am
Akero Therapeutics
clinical trials
NASH
efruxifermin
Intercept CEO lays into FDA after NASH drug rejection
Pharmaforum
Tue, 06/30/20 - 10:32 am
Intercept Pharma
Pharma CEOs
NASH
FDA
obeticholic acid
FDA rejects Intercept’s pitch for NASH as CEO fires back at the agency’s ‘evolving’ guidelines
Endpoints
Mon, 06/29/20 - 10:06 am
Intercept Pharmaceuticals
NASH
FDA
obeticholic acid
Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs
Fierce Biotech
Tue, 06/2/20 - 10:46 am
Gilead Sciences
Mark Genovese
NASH
arthritis
Intercept hits regulatory snag at FDA, likely delaying NASH drug’s approval
MedCity News
Fri, 05/22/20 - 10:43 am
Intercept Pharma
obeticholic acid
FDA
NASH
Biotech Genfit warns costs of failed NASH trial will drag deep into 2020
Fierce Biotech
Tue, 05/19/20 - 10:29 am
Genfit
NASH
clinical trials
elafibranor
Genfit Contender in Heated NASH Drug Race Fails in Phase 3 Study
Xconomy
Mon, 05/11/20 - 11:50 pm
Genfit
clinical trials
NASH
elafibranor
Novo's diabetes drug also appears to work in NASH
BioPharma Dive
Thu, 05/7/20 - 12:08 am
Novo Nordisk
NASH
semaglutide
Akero Heads to Top of Class in NASH; Genfit Says Pandemic Won’t Delay Data
Xconomy
Mon, 04/13/20 - 11:04 am
Akero
Genfit
NASH
venBio closes third fund for biopharma startup investment, valued at $394M
MedCity News
Mon, 04/6/20 - 10:28 am
venBio
NASH
startups
Akero’s success gives a new Nash mechanism hope
EP Vantage
Thu, 04/2/20 - 11:01 am
Akero Therapeutics
NASH
AKR-001
COVID-19 not expected to 'significantly delay' Genfit's phase 3 NASH readout
Fierce Biotech
Tue, 03/31/20 - 11:04 am
Genfit
NASH
clinical trials
COVID-19
elafibranor
Upcoming events – Fibroid data for Obseva, as Inventiva turns to Nash
EP Vantage
Fri, 03/6/20 - 10:49 am
ObsEva
uterine fibroids
clinical trials
NASH
Inventiva
lanifibranor
Novo bids for recognition in the year of NASH
EP Vantage
Thu, 03/5/20 - 10:39 am
NASH
Novo Nordisk
Ozempic
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »